RESEARCH-USE BIOSIMILAR ANTIBODY

Bermekimab

Monoclonal antibody · IgG1

IL1AIgG1RUO

Bermekimab (MABp1) is a human monoclonal antibody targeting interleukin-1α(IL-1α) . Bermekimab can prevent tumor-related inflammation. Bermekimab can be used in the research of atopic dermatitis.

TARGETIL1A
YMonoclonal antibody
CATALOGSC-BS-723
CATALOG NUMBERSC-BS-723
MOLECULAR WEIGHTApprox. 145.5 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Bermekimab (MABp1) is a human monoclonal antibody targeting interleukin-1α(IL-1α) . Bermekimab can prevent tumor-related inflammation. Bermekimab can be used in the research of atopic dermatitis.

Bermekimab is a recombinant research-use antibody directed against IL1A.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte